Baiyunshan Pharmaceutical to Build Guangzhou Factory For 3.2 Billion Yuan

MT Newswires Live08-05

Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:0874, SHA:600332) plans to build a centralized pharmaceutical manufacturing base in China's Guangzhou City for 3.20 billion yuan, the company said in a filing on Friday.

The facility will be built in three years, with the construction expected to be completed in December 2027, the company added.

Price (HKD): $19.70, Change: $+0.02, Percent Change: +0.10%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment